Association of the protein Z ATG haplotype with symptomatic nonvascular stroke or thromboembolism in white children: A family-based cohort study

Blood

Volumn 113, Issue 10, 2009, Pages 2336-2341

  Nowak Göttl, Ulrike ^a,b   Fröhlich, Birgit ^a   Thedieck, Sabine ^a   Huge, Andreas ^b   Stoll, Monika ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; FIBRINOGEN; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; GERMANY; HAPLOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NEWBORN; NONVASCULAR STROKE; PARENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGENY; RISK FACTOR; SCHOOL CHILD; SEX DETERMINATION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STROKE; SYMPTOM; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 64049097137     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-10-181461     Document Type: Article

References (40)

1. Earley CJ, Kittner SJ, Feeser BR, et al. Stroke in children and sickle-cell disease: Baltimore-Washington-Cooperative Young Stroke Study.Neurology. 1998;51:169-176.
2. Kirkham FJ, Prengler M, Hewes DK, Ganesan V. Risk factors for arterial ischemic stroke in children. J Child Neurol. 2000;15:299-307.
3. Haywood S, Liesner R, Pindora S, Ganesan V.Thrombophilia and first arterial ischaemic stroke: a systematic review. Arch Dis Child. 2005;90:402-405.
4. Fujimaki K, Yamazaki T, Taniwaki M, Ichinose A. The gene for human protein Z is localized to chromosome 13 at band q34 and coded by 8 regular and one alterative exon. Biochemistry. 1998;37:6838-6846.
5. Broze GJ Jr, Miletich JP. Human protein Z. J Clin Invest. 1984;73:933-938.
6. Hogg PJ, Stenflo J. Interaction of human protein Z with thrombin: evaluation of the species difference in the interaction between bovine and human protein Z and thrombin. Biochem Biophys Res Commun. 1991;178:801-807.
7. Han X, Fiehler R, Broze GJ Jr. Isolation of a protein Z-dependent plasma protease inhibitor. Proc Natl Acad Sci U S A. 1998;95:9250-9255.
8. Prowse CV, Esnouf MP. The isolation of a new warfarin-sensitive protein from bovine plasma. Biochem Soc Trans. 1977;5:255-256.
9. Miletich JP, Broze GJ Jr. Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy. Blood. 1987;69:1580-1586.
10. Ichinose A, Takeya H, Espling E, Iwanaga S, Kisiel W, Davie EW. Amino acid sequence of human protein Z, a vitamin K-dependent plasma glycoprotein. Biochem Biophys Res Commun.1990;172:1139-1144.
11. Sejima H, Hayashi T, Deyashiki T, Nishioka J,Suzuki K. Primary structure of vitamin K-dependent human protein Z. Biochem Biophys Res Commun.1990;171:661- 668.
12. Ravi S, MauronT, Lammle B, Wullemin WA. Protein Z in healthy human individuals and in patients with a bleeding tendency. Br J Haematol.1998;102: 1219-1223.
13. Broze GJ Jr. Protein Z-dependent regulation of coagulation. Thromb Haemost. 2001;86:8-13.
14. McQuillan AM, Eikelboom JW, Hankey GJ, et al. Protein Z in ischemic stroke and its etiologic subtypes. Stroke. 2003;34:2415-2419.
15. Nowak-Gottl U, Langer C, Bergs S, Thedieck S,Strater R, Stoll M. Genetics of hemostasis: differential effects of heritability and household components influencing lipid concentrations and clotting factor levels in 282 pediatric stroke families. Environ Health Perspect. 2008;116:893-843.
16. Lanthier S, Carmant L, David M, Larbrisseau A,de Veber G. Stroke in children. The coexistence of multiple risk factors predicts poor outcome.Neurology. 2000;54:371-378.
17. Williams LS, Garg BP, Cohen M, Fleck JD, Biller J. Subtypes of ischemic stroke in children and young adults. Neurology. 1997;49:1541-1545.
18. Kirkham F, Sebire G, Steinlin M, Strater R. Arterial ischaemic stroke in children. Review of the literature and strategies for future stroke studies.Thromb Haemost. 2004;92:697-706.
19. Zhang W, Collins A, Morton NE. Does haplotype diversity predict power for association mapping of disease susceptibility? Hum Genet. 2004;115: 157-164.
20. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-265.
21. Staton J, Sayer M, Hankey GJ, Cole V, Thom J, Eikelboom JW. Protein Z gene polymorphisms,protein Z concentrations, and ischaemic stroke.Stroke. 2005;36:1123-1127.
22. Kemkes-Matthes B, Matthes KJ, Souri M, Koseki-Kuno S, Ichinose A. R225h amino acid substitution of protein Z identified in patient with factor VLeiden mutation. Br J Haematol. 2005;128:248-252.
23. Nowak-Gottl U, Strater R, Heinecke A, et al.Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetet-rahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood. 1999;94:3678-3682.
24. Junker R, Koch HG, Auberger K, Munchow N,Ehrenforth S, Nowak-Gottl U. Prothrombin G20210Agene mutation and further prothrom-botic risk factors in childhood thrombophilia. Arte-rioscler Thromb Vasc Biol. 1999;19:2568-3572.
25. Kreuz W, Stoll M, Junker R, et al. Familial elevated factor VIII in children with symptomatic venous thrombosis and post-thrombotic syndrome: results of a multicenter study. Arterioscler Thromb Vasc Biol. 2006;26:1901-1906.
26. Frohlich B, Thedieck S, Kosch A, Nowak-Gottl U.Elevated protein Z is an independent risk factor in white children with venous thrombosis or stroke-a case control study [abstract]. Blood.2003;102:552A.
27. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mel-litus (IDDM). Am J Hum Genet. 1993;52:506-516.
28. Kirkwood BR, Sterne JAC. Medical Statistics. 2nd Ed. Oxford: Blackwell Science; 2003:339-342.
29. Goldstein DB. Islands of linkage disequilibrium. Nat Genet. 2001;29:109-111.
30. Johnson GCL, Esposito L, Barratt BJ, et al. Hap-lotype tagging for the identification of common disease genes. Nat Genet. 2001;29:233-237.
31. Cesari F, Fatini C, Fedi S, et al. Protein Z gene polymorphism (intron F79 G>A;-13A>G) are not associated with acute coronary syndromes.Thromb Haemost. 2006;96:98-99.
32. Sofi F, Cesari F, Gensini GF, Abbate R, Fedi S.Protein Z levels, protein Z G79Apolymorphism,and prothrombotic conditions. Stroke. 2005;36:1821.
33. Vasse M, Guegan-Massardier E, Borg JY,Woimant F, Soria C. Frequency of protein Z deficiency in patients with ischaemic stroke. Lancet.2001;357:993-994.
34. Gris JC, Quere I, Dechaud H, et al. High frequency of protein Z deficiency in patients with unexplained early fetal loss. Blood. 2002;99:2606-2608.
35. Kemkes-Matthes B, Nees M, Kuhnel G, Matzdorf A, Matthes KJ. Protein Z influences the prothrom-botic phenotype in factor V Leiden patients.Thromb Res. 2002;106:183-185.
36. Kobelt K, Biasiutti FD, Mattle HP, Lammle B, Wuillemin WA. Protein Z in ischaemic stroke. Br J Haematol. 2001;114:169-173.
37. Lichy C, Kropp S, Dong-Si T, et al. Acommon polymorphism of the protein Z gene is associated with protein Z plasma levels and with risk of cerebral ischemia in the young. Stroke. 2004;35:40-45.
38. Huang X, Swanson R, Broze JG Jr, Olson ST.Kinetic characterization of the protein Z-dependent protease inhibitor reaction with blood coagulation factor Xa. J Biol Chem 283;44:29770-29783.
39. Van de Water N, Tan T, Ashton F, et al. Mutations within the protein Z-dependent protease inhibitor gene are associated with venous thromboembolic disease: a new form of thrombophilia. Br. J Haematol. 2004;127:190-194.
40. Corral J, Gonzalez-Conejero R, Soria JM, et al. A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis. Blood. 2006;108:177-183.